Results 11 to 20 of about 46,238 (244)

Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome. [PDF]

J Peripher Nerv Syst
ABSTRACT Background and Aims Understanding of population‐level outcomes for patients with Guillain–Barré syndrome (GBS) remains limited. We identified which GBS patients are most likely to experience worse outcomes using the largest and most current GBS cohort in the United States.
Wright B, Eiffert SR, Cirincione A, Nardin J, Howard JF, Traub RE.   +5 more
europepmc   +2 more sources

Fatal recurrent Guillain–Barré syndrome (GBS) in an Ethiopian male: a case report [PDF]

Journal of Medical Case Reports
Introduction Guillain–Barré syndrome (GBS) is a disease affecting the peripheral nerves, leading to a constellation of motor, sensory, and autonomic symptoms.
Eden Tesfaye Beyene, Yonas Berhane Tesfay, Yared Getachew Tadesse, Estifanos Bekele Fole   +3 more
doaj   +2 more sources

Clinical Profile, Functional Outcome, and Mortality of Guillain-Barre Syndrome: A Five-Year Tertiary Care Experience from Nepal

Neurology Research International, 2019
Introduction. Guillain-Barre syndrome is the most common cause of acute flaccid paralysis in the adult population. It occurs at the rate of 0.34 to 4 per 100000 individuals.
Saroj Kumar Bhagat, Shrey Sidhant, Mukesh Bhatta, Ashish Ghimire, Bhupendra Shah   +4 more
doaj   +1 more source

Reversible stress cardiomyopathy in Guillain-Barré syndrome: a case report

Journal of Medical Case Reports, 2019
Background Guillain-Barré syndrome is an autoimmune disorder in which autoantibodies mainly affect the peripheral nervous system. Autonomic dysfunction is a common and severe complication of Guillain-Barré syndrome.
A. Gravos, A. Destounis, K. Katsifa, P. Tselioti, K. Sakellaridis, V. Grammatikopoulou, C. Tsapas, A. Nodarou, P. Batiani, A. Prekates   +9 more
doaj   +1 more source

Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination [PDF]

, 2013
Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between
Beghi, E, Benedetti, M D, Chiò, A, D'Alessandro, R, Filippini, G, Galeotti, F, Granieri, E, Itang, study group., Logroscino, G, Massari, M, Pugliatti, M, Raschetti, R, Santuccio, C   +12 more
core   +1 more source

Guillain-Barre Syndrome

Surgical Neurology, 1997
G uillain-Barre Syndrome (GBS) is characterized by rapidly progressive symmetric paralysis. The presenting symptoms are often most prominent in the proximal lower extremities and subsequently advance to involve the upper extremities. Bilateral facial weakness is common as well. Areflexia typically develops early in the course of the syndrome.
  +6 more sources

Concomitant Guillain–Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis

BMC Gastroenterology, 2022
Background Guillain–Barré Syndrome is an immune mediated polyneuropathy. Ulcerative Colitis is an immune mediated chronic inflammatory condition mainly of the large intestine. Guillain–Barré Syndrome can present as a rare extraintestinal manifestation of
Jayasundara Mudiyanselage Hishali Dahami Jayasundara, Vajira Tharanga Samarawickrama, Ranjith Peiris, Tilan Aponso, Danushi Abeynayake   +4 more
doaj   +1 more source

Guillain-Barré syndrome: a century of progress [PDF]

, 2016
In 1916, Guillain, Barré and Strohl reported on two cases of acute flaccid paralysis with high cerebrospinal fluid protein levels and normal cell counts — novel findings that identified the disease we now know as Guillain–Barré syndrome (GBS).
A Campbell, A Chiba, A Chiba, A Pestronk, A Uncini, AA Ilyas, AD Langmuir, AJ Sumner, AK Asbury, AK Asbury, AK Asbury, AM Fitzpatrick, B Parra, B van den Berg, BH Waksman, C Brechenmacher, C Fokke, C Hafer-Macko, C Linington, CE Hafer-Macko, CL Schengrund, CP O'Leary, E Díez-Tejedor, FG van der Meché, FH Geisler, G Guillain, GM McKhann, GM O'Hanlon, H Wis´niewski, HJ Willison, Hugh J. Willison, J Kaldor, J Matias-Guiu, JA Goodfellow, JC Dodge, JG McLeod, JH Rees, JJ Plomp, JM Pearce, John A. Goodfellow, JW Albers, JW Griffin, JW Prineas, K Kaida, K Susuki, KE Astrom, KM Rhodes, KN Greenshields, LB Schonberger, LD Osler, LM Araujo, LT Kurland, M Fisher, M Kadlubowski, M Vermeulen, MK White, N Shahrizaila, N Yuki, N Yuki, N Yuki, N Yuki, NA Gregson, O Landry, PA van Doorn, PO Osterman, R McGonigal, R McGonigal, R van Koningsveld, RA Hughes, RA Hughes, RJ Greenwood, RP Kleyweg, S Draganescu, S Kusunoki, S Lafontaine, S Rinaldi, S Rinaldi, S Rinaldi, SK Halstead, SK Halstead, SK Halstead, T Lasky, T Saida, TE Feasby, TE Feasby, TW Ho, TW Ho, VM Cao-Lormeau, W Wiederholt, W Yan, WE Haymaker, Y Nagai   +91 more
core   +1 more source

Specificity of recovery in acute motor axonal neuropathy with conduction blocks on the example of two clinical cases

Нервно-мышечные болезни, 2020
Introduction. The heterogeneity of the forms and severity of Guillain-Barre syndrome explains the variability of recovery: from rapid and complete (in most cases) to slow with the development of persistent residual deficiency (rarely).
D. A. Grishina, N. A. Suponeva
doaj   +1 more source

C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy [PDF]

, 2016
Introduction Guillain-Barré syndrome (GBS) is an autoimmune disease that results in acute paralysis through inflammatory attack on peripheral nerves, and currently has limited, non-specific treatment options.
Barrie, Jennifer A., Cunningham, Madeleine E., Fewou, Simon N., Furukawa, Koichi, McGonigal, Rhona, Sankaranarayanan, Sethu, Willison, Hugh J., Yao, Denggao, Yednock, Ted A.   +8 more
core   +2 more sources